{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-22-000007","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2022-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.120382+00:00","generated_at":"2026-06-27T19:56:18.643390+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Immunovant to present corporate overview at J.P. Morgan Healthcare Conference on Jan 13, 2022","bullets":["CEO Pete Salzmann to present on Thursday, January 13, 2022 at 9:45am ET.","Webcast available via investor relations section of Immunovant's website.","No new financial or clinical data announced in the press release.","Presentation is part of the 40th Annual J.P. Morgan Healthcare Conference (Jan 10-13)."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-22-000007","json":"https://secwatch.observer/filing/0001764013-22-000007.json","markdown":"https://secwatch.observer/filing/0001764013-22-000007.md","text":"https://secwatch.observer/filing/0001764013-22-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000007/0001764013-22-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000007/imvt-20220107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T19:56:18.643390+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}